Anti obesity Drugs Market
Anti-obesity Drugs Market Research Report Information by Treatment Type (Appetite Suppressants (Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin 2C Receptor Agonists, Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs)), Lipase Inhibitors, GLP-1 Receptor Agonists, Combination Drugs, Others), by Drug Type (Prescription Drugs and Over the Counter Drugs), by Mechanism of Action (Centrally Acting Anti-Obesity Drugs and Peripherally Acting Anti-Obesity Drugs), by Route of Administration (Oral and Subcutaneous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa) - Forecast till 2035
Anti-obesity Drugs Market Overview
The Anti-obesity Drugs Market was valued at USD 12.27 billion in 2024. The Anti-obesity Drugs Market industry is projected to grow from USD 13.33 billion in 2025 to USD 30.81 billion by 2035, exhibiting a compoun..